Paracetamol-AFT paracetamol 1000 mg/100 mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

paracetamol-aft paracetamol 1000 mg/100 ml injection vial

aft pharmaceuticals pty ltd - paracetamol, quantity: 10 mg/ml - injection, intravenous infusion - excipient ingredients: hydrochloric acid; cysteine hydrochloride monohydrate; dibasic sodium phosphate dihydrate; mannitol; nitrogen; water for injections; sodium hydroxide - paracetamol-aft 10mg/ml, solution for infusion is indicated for the relief of mild to moderate pain and the reduction of fever where an intravenous route of administration is considered clinically necessary.

Paracetamol 120mg/5ml Oral Suspension Malta - English - Medicines Authority

paracetamol 120mg/5ml oral suspension

rosemont pharmaceuticals limited rosemont house, yorkdale industrial park, braithwaite street, leeds ls11 9xe, united kingdom - paracetamol - oral suspension - paracetamol 120 mg/5ml - analgesics

PANADOL OSTEO (reformulation)  paracetamol 665 mg modified release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

panadol osteo (reformulation) paracetamol 665 mg modified release tablet blister pack

haleon australia pty ltd - paracetamol, quantity: 665 mg - tablet, modified release - excipient ingredients: magnesium stearate; stearic acid; povidone; pregelatinised maize starch; hypromellose; carnauba wax; croscarmellose sodium; triacetin - effective relief from persistent pain for up to 8 hours. effective for the relief of persistent pain associated with osteoarthritis and muscular aches and pains such as backache. provides effective temporary relief of pain and discomfort associated with: headache, tension headache, cold and flu, period pain, toothache and pain after dental procedures. reduces fever.

PARACETAMOL KABI paracetamol 500mg/50mL solution for injection in freeflex bag Australia - English - Department of Health (Therapeutic Goods Administration)

paracetamol kabi paracetamol 500mg/50ml solution for injection in freeflex bag

fresenius kabi australia pty ltd - paracetamol, quantity: 10 mg/ml - injection, solution - excipient ingredients: cysteine hydrochloride monohydrate; mannitol; water for injections; nitrogen - paracetamol 10 mg/ml, solution for infusion is indicated for the relief of mild to moderate pain and the reduction of fever where an intravenous route of administration is considered clinically necessary.

PARACETAMOL KABI paracetamol 1000mg/100mL solution for injection in freeflex bag Australia - English - Department of Health (Therapeutic Goods Administration)

paracetamol kabi paracetamol 1000mg/100ml solution for injection in freeflex bag

fresenius kabi australia pty ltd - paracetamol, quantity: 10 mg/ml - injection, solution - excipient ingredients: cysteine hydrochloride monohydrate; nitrogen; mannitol; water for injections - paracetamol 10 mg/ml, solution for infusion is indicated for the relief of mild to moderate pain and the reduction of fever where an intravenous route of administration is considered clinically necessary.

PARACETAMOL KABI paracetamol 500mg/50mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

paracetamol kabi paracetamol 500mg/50ml solution for injection vial

fresenius kabi australia pty ltd - paracetamol, quantity: 10 mg/ml - injection, solution - excipient ingredients: cysteine hydrochloride monohydrate; mannitol; water for injections; nitrogen - paracetamol 10 mg/ml, solution for infusion is indicated for the relief of mild to moderate pain and the reduction of fever where an intravenous route of administration is considered clinically necessary.

PARACETAMOL KABI paracetamol 1000mg/100mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

paracetamol kabi paracetamol 1000mg/100ml solution for injection vial

fresenius kabi australia pty ltd - paracetamol, quantity: 10 mg/ml - injection, solution - excipient ingredients: cysteine hydrochloride monohydrate; nitrogen; mannitol; water for injections - paracetamol 10 mg/ml, solution for infusion is indicated for the relief of mild to moderate pain and the reduction of fever where an intravenous route of administration is considered clinically necessary.

PANADOL OSTEO paracetamol 665mg modified release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

panadol osteo paracetamol 665mg modified release tablet blister pack

haleon australia pty ltd - paracetamol, quantity: 665 mg - tablet, modified release - excipient ingredients: hypromellose; pregelatinised maize starch; triacetin; carnauba wax; magnesium stearate; croscarmellose sodium; povidone; stearic acid - effective relief from persistent pain for up to 8 hours. effective for the relief of persistent pain associated with osteoarthritis and muscular aches and pains such as backache. provides effective temporary relief of pain and discomfort associated with: headache, tension headache, cold and flu, period pain, toothache and pain after dental procedures. reduces fever.

PARACETAMOL IV PFIZER Australia - English - Department of Health (Therapeutic Goods Administration)

paracetamol iv pfizer

pfizer australia pty ltd - paracetamol, quantity: 1 g - injection, solution - excipient ingredients: glucose monohydrate; sodium citrate dihydrate; water for injections; glacial acetic acid; hydrochloric acid; sodium acetate trihydrate; sodium hydroxide - for the relief of mild to moderate pain and the reduction of fever where an intravenous route of administration is considered clinically necessary.

PARACETAMOL IV PFIZER Australia - English - Department of Health (Therapeutic Goods Administration)

paracetamol iv pfizer

pfizer australia pty ltd - paracetamol, quantity: 500 mg - injection, solution - excipient ingredients: hydrochloric acid; sodium citrate dihydrate; sodium acetate trihydrate; glucose monohydrate; sodium hydroxide; glacial acetic acid; water for injections - for the relief of mild to moderate pain and the reduction of fever where an intravenous route of administration is considered clinically necessary.